These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease. Reynolds NC, Prost RW, Mark LP. Brain Res; 2005 Jan 07; 1031(1):82-9. PubMed ID: 15621015 [Abstract] [Full Text] [Related]
3. MR-spectroscopic findings in juvenile-onset Huntington's disease. Reynolds NC, Prost RW, Mark LP, Joseph SA. Mov Disord; 2008 Oct 15; 23(13):1931-5. PubMed ID: 18759332 [Abstract] [Full Text] [Related]
4. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy. Lin K, Carrete H, Lin J, Peruchi MM, de Araújo Filho GM, Guaranha MS, Guilhoto LM, Sakamoto AC, Yacubian EM. Epilepsia; 2009 May 15; 50(5):1191-200. PubMed ID: 19220412 [Abstract] [Full Text] [Related]
5. Is brain lactate increased in Huntington's disease? Martin WR, Wieler M, Hanstock CC. J Neurol Sci; 2007 Dec 15; 263(1-2):70-4. PubMed ID: 17655868 [Abstract] [Full Text] [Related]
6. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease. Villanueva V, Alvarez-Linera J, Gómez-Garre P, Gutiérrez J, Serratosa JM. Epilepsia; 2006 Apr 15; 47(4):788-92. PubMed ID: 16650146 [Abstract] [Full Text] [Related]
8. (1)H-MR spectroscopy indicates prominent cerebellar dysfunction in benign adult familial myoclonic epilepsy. Striano P, Caranci F, Di Benedetto R, Tortora F, Zara F, Striano S. Epilepsia; 2009 Jun 15; 50(6):1491-7. PubMed ID: 19054410 [Abstract] [Full Text] [Related]
9. Spectroscopic magnetic resonance imaging of the brain: voxel localisation and tissue segmentation in the follow up of brain tumour. Poloni G, Bastianello S, Vultaggio A, Pozzi S, Maccabelli G, Germani G, Chiarati P, Pichiecchio A. Funct Neurol; 2008 Jun 15; 23(4):207-13. PubMed ID: 19331784 [Abstract] [Full Text] [Related]
10. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Gruber S, Pinker K, Riederer F, Chmelík M, Stadlbauer A, Bittsanský M, Mlynárik V, Frey R, Serles W, Bodamer O, Moser E. Eur J Radiol; 2008 Nov 15; 68(2):320-7. PubMed ID: 17964104 [Abstract] [Full Text] [Related]
11. Decreased frontal choline and neuropsychological performance in preclinical Huntington disease. Gómez-Ansón B, Alegret M, Muñoz E, Sainz A, Monte GC, Tolosa E. Neurology; 2007 Mar 20; 68(12):906-10. PubMed ID: 17372125 [Abstract] [Full Text] [Related]
12. Evaluation of functional MRI markers in mild cognitive impairment. Zhang B, Li M, Sun ZZ, Zhu B, Yuan L, Wang Y, Xu Y. J Clin Neurosci; 2009 May 20; 16(5):635-41. PubMed ID: 19264490 [Abstract] [Full Text] [Related]
13. Intraindividual variability of striatal (1)H-MRS brain metabolite measurements at 3 T. Soreni N, Noseworthy MD, Cormier T, Oakden WK, Bells S, Schachar R. Magn Reson Imaging; 2006 Feb 20; 24(2):187-94. PubMed ID: 16455408 [Abstract] [Full Text] [Related]
14. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias. Guerrini L, Belli G, Mazzoni L, Foresti S, Ginestroni A, Della Nave R, Diciotti S, Mascalchi M. J Magn Reson Imaging; 2009 Jul 20; 30(1):11-7. PubMed ID: 19557841 [Abstract] [Full Text] [Related]
15. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III. Vagnozzi R, Signoretti S, Tavazzi B, Floris R, Ludovici A, Marziali S, Tarascio G, Amorini AM, Di Pietro V, Delfini R, Lazzarino G. Neurosurgery; 2008 Jun 20; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995 [Abstract] [Full Text] [Related]
16. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey. García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C. Dement Geriatr Cogn Disord; 2008 Jun 20; 26(1):15-25. PubMed ID: 18566544 [Abstract] [Full Text] [Related]
17. 1H magnetic resonance spectroscopy study of thalamus in treatment resistant depressive patients. Mu J, Xie P, Yang ZS, Yang DL, Lv FJ, Luo TY, Li Y. Neurosci Lett; 2007 Sep 20; 425(1):49-52. PubMed ID: 17723272 [Abstract] [Full Text] [Related]
18. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. Gabis L, Wei Huang, Azizian A, DeVincent C, Tudorica A, Kesner-Baruch Y, Roche P, Pomeroy J. J Child Neurol; 2008 Jul 20; 23(7):766-74. PubMed ID: 18487520 [Abstract] [Full Text] [Related]
19. Proton magnetic resonance spectroscopy in school-aged autistic children. Vasconcelos MM, Brito AR, Domingues RC, da Cruz LC, Gasparetto EL, Werner J, Gonçalves JP. J Neuroimaging; 2008 Jul 20; 18(3):288-95. PubMed ID: 18304036 [Abstract] [Full Text] [Related]
20. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder. Atmaca M, Yildirim H, Ozdemir H, Koc M, Ozler S, Tezcan E. Psychiatry Clin Neurosci; 2009 Aug 20; 63(4):486-90. PubMed ID: 19531109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]